Lidocaine hydrochloride in plastic container and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lidocaine hydrochloride in plastic container and Furosemide. Common interactions include dizziness among females and hypotension among males.

The phase IV clinical study analyzes what interactions people who take Lidocaine hydrochloride in plastic container and Furosemide have. It is created by eHealthMe based on reports of 15 people who take Lidocaine hydrochloride in plastic container and Furosemide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 03, 2022

15 people who take Lidocaine hydrochloride in plastic container and Furosemide together, and have interactions are studied.


What is Lidocaine hydrochloride in plastic container?

Lidocaine hydrochloride in plastic container has active ingredients of lidocaine hydrochloride. eHealthMe is studying from 116 Lidocaine hydrochloride in plastic container users for its effectiveness, alternative drugs and more.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 276,826 Furosemide users for its effectiveness, alternative drugs and more.

Number of Lidocaine hydrochloride in plastic container and Furosemide reports submitted per year:

Lidocaine hydrochloride in plastic container and Furosemide drug interactions.

Common Lidocaine Hydrochloride In Plastic Container and Furosemide drug interactions by gender *:

female:

  1. Dizziness
  2. Haematuria
  3. Heart rate decreased
  4. Intestinal infarction
  5. Metabolic acidosis
  6. Pyrexia
  7. Sepsis
  8. Swelling face
  9. Angina pectoris
  10. Drug ineffective

male:

  1. Hypotension
  2. Circulatory collapse
  3. Asthenia
  4. Astigmatism
  5. Back pain
  6. Bladder cancer
  7. Blepharitis
  8. Blood calcium decreased
  9. Blood immunoglobulin g increased
  10. Bone disorder

Common Lidocaine Hydrochloride In Plastic Container and Furosemide drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Asthenia
  2. Cardiomyopathy
  3. Dyspnoea
  4. Enterobacter pneumonia
  5. Epistaxis
  6. Heart rate decreased
  7. Hyperglycaemia
  8. Hypotension
  9. Ileus
  10. Intestinal infarction

20-29:

n/a

30-39:

n/a

40-49:

  1. Angina pectoris
  2. Abdominal pain
  3. Animal bite
  4. Arthralgia
  5. Benign neoplasm of thyroid gland
  6. Bone disorder
  7. Colon neoplasm
  8. Decreased interest
  9. Defaecation urgency
  10. Depression

50-59:

  1. Mucosal inflammation
  2. Nausea
  3. Oropharyngeal pain
  4. Pain
  5. Pulmonary oedema
  6. Sepsis
  7. Subarachnoid haemorrhage
  8. Syncope
  9. Tachycardia
  10. Abdominal pain

60+:

  1. Hypotension
  2. Dyspnoea
  3. Lethargy
  4. Pyrexia
  5. Sepsis
  6. Abnormal sensation in eye
  7. Anaemia of chronic disease
  8. Anxiety
  9. Aortic aneurysm
  10. Astigmatism

Common conditions people have *:

  1. Pain: 7 people, 46.67%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 33.33%
  3. Weakness: 1 person, 6.67%
  4. Insomnia (sleeplessness): 1 person, 6.67%
  5. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 6.67%
  6. Back Pain: 1 person, 6.67%
  7. Breakthrough Pain: 1 person, 6.67%
  8. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
  9. Constipation: 1 person, 6.67%
  10. Depression: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lidocaine hydrochloride in plastic container and Furosemide?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Lidocaine hydrochloride in plastic container and Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Furosemide side effects:

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Furosemide interactions:

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine hydrochloride and furosemide (the active ingredients of Lidocaine hydrochloride in plastic container and Furosemide, respectively), and Lidocaine hydrochloride in plastic container and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lidocaine hydrochloride in plastic container and Furosemide.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: